Skip to content

Clinical trials

Phase 3 Neoplasms by Site trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Phase: Phase 3 Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20102
20111
20141
20151
20162
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.2
Abbott1
Bioniche Life Sciences Inc.1
Celgene1
Eli Lilly and Company1
Hoffmann-La Roche1
Medical Enterprises Europe B.V.1
Novartis Pharmaceuticals1
Steba Biotech S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms10
Neoplasms by Site10
Adenocarcinoma4
Digestive System Diseases4
Digestive System Neoplasms4
Neoplasms by Histologic Type4
Carcinoma3
Neoplasms, Glandular and Epithelial3
Carcinoma, Bronchogenic2
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.